SMN protein deficiency, disrupted fatty acid metabolism, muscle wasting, mitochondrial dysfunction, and compromised nutritional status may decrease Crn levels among SMA patients [20]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.